APOE and CD33 expressions were especially high (and SORL1 expression and FDG PET SUVR were especially low) in regions most susceptible to Alzheimer’s disease, such as para-hippocampus and entorhinal cortex. This evidence concerns the gene APOE and Alzheimer disease.